Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 20
2012 68
2013 94
2014 118
2015 204
2016 269
2017 462
2018 547
2019 444
2020 55
Text availability
Article attribute
Article type
Publication date

Search Results

2,031 results
Results by year
Filters applied: . Clear all
Page 1
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Xu-Monette ZY, Zhou J, Young KH. Xu-Monette ZY, et al. Blood. 2018 Jan 4;131(1):68-83. doi: 10.1182/blood-2017-07-740993. Epub 2017 Nov 8. Blood. 2018. PMID: 29118007 Free PMC article. Review.
PD-L1.
Kythreotou A, Siddique A, Mauri FA, Bower M, Pinato DJ. Kythreotou A, et al. J Clin Pathol. 2018 Mar;71(3):189-194. doi: 10.1136/jclinpath-2017-204853. Epub 2017 Nov 2. J Clin Pathol. 2018. PMID: 29097600 Free article. Review.
Overcoming T cell exhaustion in infection and cancer.
Pauken KE, Wherry EJ. Pauken KE, et al. Trends Immunol. 2015 Apr;36(4):265-76. doi: 10.1016/j.it.2015.02.008. Epub 2015 Mar 18. Trends Immunol. 2015. PMID: 25797516 Free PMC article. Review.
Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.
Li CW, Lim SO, Chung EM, Kim YS, Park AH, Yao J, Cha JH, Xia W, Chan LC, Kim T, Chang SS, Lee HH, Chou CK, Liu YL, Yeh HC, Perillo EP, Dunn AK, Kuo CW, Khoo KH, Hsu JL, Wu Y, Hsu JM, Yamaguchi H, Huang TH, Sahin AA, Hortobagyi GN, Yoo SS, Hung MC. Li CW, et al. Cancer Cell. 2018 Feb 12;33(2):187-201.e10. doi: 10.1016/j.ccell.2018.01.009. Cancer Cell. 2018. PMID: 29438695 Free PMC article.
Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.
Kao JC, Liao B, Markovic SN, Klein CJ, Naddaf E, Staff NP, Liewluck T, Hammack JE, Sandroni P, Finnes H, Mauermann ML. Kao JC, et al. JAMA Neurol. 2017 Oct 1;74(10):1216-1222. doi: 10.1001/jamaneurol.2017.1912. JAMA Neurol. 2017. PMID: 28873125 Free PMC article.
Programmed cell death-1 inhibition in lymphoma.
Hawkes EA, Grigg A, Chong G. Hawkes EA, et al. Lancet Oncol. 2015 May;16(5):e234-45. doi: 10.1016/S1470-2045(15)70103-8. Lancet Oncol. 2015. PMID: 25943068 Review.
PD-1/PD-L1 inhibitors.
Sunshine J, Taube JM. Sunshine J, et al. Curr Opin Pharmacol. 2015 Aug;23:32-8. doi: 10.1016/j.coph.2015.05.011. Epub 2015 Jun 2. Curr Opin Pharmacol. 2015. PMID: 26047524 Free PMC article. Review.
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy.
Wang M, Yao LC, Cheng M, Cai D, Martinek J, Pan CX, Shi W, Ma AH, De Vere White RW, Airhart S, Liu ET, Banchereau J, Brehm MA, Greiner DL, Shultz LD, Palucka K, Keck JG. Wang M, et al. FASEB J. 2018 Mar;32(3):1537-1549. doi: 10.1096/fj.201700740R. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29146734 Free PMC article.
2,031 results
Jump to page
Feedback